Literature for peptidase A01.023: plasmepsin-2

Summary Alignment Sequences Sequence features Distribution Structure Literature Substrates Pharma

(Topics flags: A Assay, S Structure, K Knockout, I Inhibitor, E Expression, V Review. To select only the references relevant to a single topic, click the link above. See explanation.)

    2026
  1. Syed,S.F., Thakur,P., Patil,M. and Choudhary,S.<br>Physico-Chemical Insights into the Catalytic Inhibition of Plasmodium falciparum Plasmepsin II Activity by Repurposing Fluoroquinolone Drugs<br>J Phys Chem B (2026) 130, 2015-2030. PubMed  Europe PubMed DOI
  2. 2024
  3. Mishra,V., Deshmukh,A., Rathore,I., Chakraborty,S., Patankar,S., Gustchina,A., Wlodawer,A., Yada,R.Y. and Bhaumik,P.<br>Inhibition of Plasmodium falciparum plasmepsins by drugs targeting HIV-1 protease: A way forward for antimalarial drug discovery<br>Curr Res Struct Biol (2024) 7, 100128-100128. PubMed  Europe PubMed DOI  PMC  EPMC  I
  4. 2023
  5. Meller,A., Bhakat,S., Solieva,S. and Bowman,G.R.<br>Accelerating Cryptic Pocket Discovery Using AlphaFold<br>J Chem Theory Comput (2023) 19, 4355-4363. PubMed  Europe PubMed DOI
  6. 2022
  7. Bhakat,S. and Soderhjelm,P.<br>Flap Dynamics in Pepsin-Like Aspartic Proteases: A Computational Perspective Using Plasmepsin-II and BACE-1 as Model Systems<br>J Chem Inf Model (2022) 62, 914-926. PubMed  Europe PubMed DOI  PMC  EPMC
  8. En-Nahli,F., Baammi,S., Hajji,H., Alaqarbeh,M., Lakhlifi,T. and Bouachrine,M.<br>High-throughput virtual screening approach of natural compounds as target inhibitors of plasmepsin-II<br>J Biomol Struct Dyn (2022) , 1-11. PubMed  Europe PubMed DOI
  9. 2020
  10. Asua,V., Conrad,M.D., Aydemir,O., Duvalsaint,M., Legac,J., Duarte,E., Tumwebaze,P., Chin,D.M., Cooper,R.A., Yeka,A., Kamya,M.R., Dorsey,G., Nsobya,S.L., Bailey,J. and Rosenthal,P.J.<br>Changing Prevalence of Potential Mediators of Aminoquinoline, Antifolate, and Artemisinin Resistance Across Uganda<br>J Infect Dis (2020) PubMed  Europe PubMed DOI  I
  11. Manhas,A., Kumar,S. and Jha,P.C.<br>Identification of the natural compound inhibitors against Plasmodium falciparum plasmepsin-II via common feature based screening and molecular dynamics simulations<br>J Biomol Struct Dyn (2020) , 1-13. PubMed  Europe PubMed DOI
  12. Nasamu,A.S., Polino,A.J., Istvan,E.S. and Goldberg,D.E.<br>Malaria parasite plasmepsins: more than just plain old degradative pepsins<br>J Biol Chem (2020) PubMed  Europe PubMed DOI
  13. 2019
  14. Bobrovs,R., Jaudzems,K. and Jirgensons,A.<br>Exploiting structural dynamics to design open-flap inhibitors of malarial aspartic proteases<br>J Med Chem (2019) 62, 8931-8950. PubMed  Europe PubMed DOI  I
  15. 2018
  16. Inoue,J., Silva,M., Fofana,B., Sanogo,K., Martensson,A., Sagara,I., Bjorkman,A., Veiga,M.I., Ferreira,P.E., Djimde,A. and Gil,J.P.<br>Piperaquine resistance in Plasmodium falciparum, West Africa<br>Emerg Infect Dis (2018) 24 PubMed  Europe PubMed DOI
  17. Kinena,L., Leitis,G., Kanepe-Lapsa,I., Bobrovs,R., Jaudzems,K., Ozola,V., Suna,E. and Jirgensons,A.<br>Azole-based non-peptidomimetic plasmepsin inhibitors<br>Arch Pharm (Weinheim) (2018) 351, e1800151-e1800151. PubMed  Europe PubMed DOI  I
  18. Kumar Singh,A., Rajendran,V., Singh,S., Kumar,P., Kumar,Y., Singh,A., Miller,W., Potemkin,V., Poonam, Grishina,M., Gupta,N., Kempaiah,P., Durvasula,R., Singh,B.K., Dunn,B.M. and Rathi,B.<br>Antiplasmodial activity of hydroxyethylamine analogs: synthesis, biological activity and structure activity relationship of plasmepsin inhibitors<br>Bioorg Med Chem (2018) 26, 3837-3844. PubMed  Europe PubMed DOI  I
  19. Mishra,V., Rathore,I., Arekar,A., Sthanam,L.K., Xiao,H., Kiso,Y., Sen,S., Patankar,S., Gustchina,A., Hidaka,K., Wlodawer,A., Yada,R.Y. and Bhaumik,P.<br>Deciphering the mechanism of potent peptidomimetic inhibitors targeting plasmepsins - biochemical and structural insights<br>FEBS J (2018) 285, 3077-3096. PubMed  Europe PubMed DOI  S  I
  20. Rasina,D., Stakanovs,G., Borysov,O.V., Pantelejevs,T., Bobrovs,R., Kanepe-Lapsa,I., Tars,K., Jaudzems,K. and Jirgensons,A.<br>2-Aminoquinazolin-4(3H)-one based plasmepsin inhibitors with improved hydrophilicity and selectivity<br>Bioorg Med Chem (2018) 26, 2488-2500. PubMed  Europe PubMed DOI  I
  21. Robert,M.G., Foguim Tsombeng,F., Gendrot,M., Mosnier,J., Amalvict,R., Benoit,N., Torrentino-Madamet,M. and Pradines,B.<br>Absence of high level of duplication of the plasmepsin 2 gene in Africa<br>Antimicrob Agents Chemother (2018) 62, e00374-18-e00374-18. PubMed  Europe PubMed DOI
  22. Santos Souza,S., L'Episcopia,M., Severini,C., Udhayakumar,V. and Lucchi,N.W.<br>Photo-Induced Electron Transfer Real-Time PCR for Detection of Plasmodium falciparum plasmepsin 2 gene copy number<br>Antimicrob Agents Chemother (2018) 62, e00317-18-e00317-18. PubMed  Europe PubMed DOI
  23. 2017
  24. Kumar,P., Kaalia,R., Srinivasan,A. and Ghosh,I.<br>Multiple target-based pharmacophore design from active site structures<br>SAR QSAR Environ Res (2017) , 1-19. PubMed  Europe PubMed DOI  I
  25. 2016
  26. Guerra,Y., Valiente,P.A., Pons,T., Berry,C. and Rudino-Pinera,E.<br>Structures of a bi-functional Kunitz-type STI family inhibitor of serine and aspartic proteases: could the aspartic protease inhibition have evolved from a canonical serine protease-binding loop?<br>J Struct Biol (2016) 195, 259-271. PubMed  Europe PubMed DOI  S
  27. Jaafar,A.H., Xiao,H., Dee,D.R., Bryksa,B.C., Bhaumik,P. and Yada,R.Y.<br>The prosegment catalyzes native folding of Plasmodium falciparum plasmepsin II<br>Biochim Biophys Acta (2016) 1864, 1356-1362. PubMed  Europe PubMed DOI
  28. Ponsuwanna,P., Kochakarn,T., Bunditvorapoom,D., Kumpornsin,K., Otto,T.D., Ridenour,C., Chotivanich,K., Wilairat,P., White,N.J., Miotto,O. and Chookajorn,T.<br>Comparative genome-wide analysis and evolutionary history of haemoglobin-processing and haem detoxification enzymes in malarial parasites<br>Malar J (2016) 15, 51-51. PubMed  Europe PubMed DOI  PMC  EPMC
  29. Rasina,D., Otikovs,M., Leitans,J., Recacha,R., Borysov,O.V., Kanepe-Lapsa,I., Domraceva,I., Pantelejevs,T., Tars,K., Blackman,M.J., Jaudzems,K. and Jirgensons,A.<br>Fragment-based discovery of 2-aminoquinazolin-4(3h)-ones as novel class nonpeptidomimetic inhibitors of the plasmepsins I, II, and IV<br>J Med Chem (2016) 59, 374-387. PubMed  Europe PubMed DOI  I
  30. 2015
  31. Dan,N. and Bhakat,S.<br>New paradigm of an old target: an update on structural biology and current progress in drug design towards plasmepsin II<br>Eur J Med Chem (2015) 95, 324-348. PubMed  Europe PubMed DOI
  32. Karubiu,W., Bhakat,S., McGillewie,L. and Soliman,M.E.<br>Flap dynamics of plasmepsin proteases: insight into proposed parameters and molecular dynamics<br>Mol Biosyst (2015) 11, 1061-1066. PubMed  Europe PubMed DOI  S
  33. McGillewie,L. and Soliman,M.E.<br>Flap flexibility amongst plasmepsins I, II, III, IV, and V: sequence, structural, and molecular dynamics analyses<br>Proteins (2015) 83, 1693-1705. PubMed  Europe PubMed DOI
  34. Recacha,R., Leitans,J., Akopjana,I., Aprupe,L., Trapencieris,P., Jaudzems,K., Jirgensons,A. and Tars,K.<br>Structures of plasmepsin II from Plasmodium falciparum in complex with two hydroxyethylamine-based inhibitors<br>Acta Crystallogr F Struct Biol Commun (2015) 71, 1531-1539. PubMed  Europe PubMed DOI  S  I
  35. Singh,A.K., Rathore,S., Tang,Y., Goldfarb,N.E., Dunn,B.M., Rajendran,V., Ghosh,P.C., Singh,N., Latha,N., Singh,B.K., Rawat,M. and Rathi,B.<br>Hydroxyethylamine based phthalimides as new class of plasmepsin hits: design, synthesis and antimalarial evaluation<br>PLoS ONE (2015) 10, e0139347-e0139347. PubMed  Europe PubMed DOI  PMC  EPMC  I
  36. 2014
  37. Jin,H., Xu,Z., Cui,K., Zhang,T., Lu,W. and Huang,J.<br>Dietary flavonoids fisetin and myricetin: dual inhibitors of Plasmodium falciparum falcipain-2 and plasmepsin II<br>Fitoterapia (2014) 94, 55-61. PubMed  Europe PubMed DOI  I
  38. Lerdsirisuk,P., Maicheen,C. and Ungwitayatorn,J.<br>Antimalarial activity of HIV-1 protease inhibitor in chromone series<br>Bioorg Chem (2014) 57, 142-147. PubMed  Europe PubMed DOI  I
  39. Meyers,M.J., Tortorella,M.D., Xu,J., Qin,L., He,Z., Lang,X., Zeng,W., Xu,W., Qin,L., Prinsen,M.J., Sverdrup,F.M., Eickhoff,C.S., Griggs,D.W., Oliva,J., Ruminski,P.G., Jacobsen,E.J., Campbell,M.A., Wood,D.C., Goldberg,D.E., Liu,X., Lu,Y., Lu,X., Tu,Z., Lu,X., Ding,K. and Chen,X.<br>Evaluation of aminohydantoins as a novel class of antimalarial agents<br>ACS Med Chem Lett (2014) 5, 89-93. PubMed  Europe PubMed DOI  PMC  EPMC  I
  40. Miura,T., Hidaka,K., Azai,Y., Kashimoto,K., Kawasaki,Y., Chen,S.E., de Freitas,R.F., Freire,E. and Kiso,Y.<br>Optimization of plasmepsin inhibitor by focusing on similar structural feature with chloroquine to avoid drug-resistant mechanism of Plasmodium falciparum<br>Bioorg Med Chem Lett (2014) 24, 1698-1701. PubMed  Europe PubMed DOI  I
  41. 2013
  42. Aureggi,V., Ehmke,V., Wieland,J., Schweizer,W.B., Bernet,B., Bur,D., Meyer,S., Rottmann,M., Freymond,C., Brun,R., Breit,B. and Diederich,F.<br>Potent inhibitors of malarial aspartic proteases, the plasmepsins, by hydroformylation of substituted 7-azanorbornenes<br>Chemistry (2013) 19, 155-164. PubMed  Europe PubMed DOI  I
  43. Bhattacharjya Sharma,R. and Chetia,D.<br>Docking studies on quinine analogs for plasmepsin-II of malaria parasite using bioinformatics tools<br>Int J Pharmcy Pharm Sci (2013) 5, 681-685.  I
  44. Chugh,M., Sundararaman,V., Kumar,S., Reddy,V.S., Siddiqui,W.A., Stuart,K.D. and Malhotra,P.<br>Protein complex directs hemoglobin-to-hemozoin formation in Plasmodium falciparum<br>Proc Natl Acad Sci U S A (2013) 110, 5392-5397. PubMed  Europe PubMed DOI
  45. de Oliveira,M.E., Cenzi,G., Nunes,R.R., Andrighetti,C.R., de Sousa Valadao,D.M., Dos Reis,C., Simoes,C.M., Nunes,R.J., Junior,M.C., Taranto,A.G., Sanchez,B.A., Viana,G.H. and de Pilla Varotti,F.<br>Antimalarial activity of 4-metoxychalcones: Docking studies as falcipain/plasmepsin inhibitors, ADMET and lipophilic efficiency analysis to identify a putative oral lead candidate<br>Molecules (2013) 18, 15276-15287. PubMed  Europe PubMed DOI  I
  46. Song,Y., Jin,H., Liu,X., Zhu,L., Huang,J. and Li,H.<br>Discovery of non-peptide inhibitors of plasmepsin II by structure-based virtual screening<br>Bioorg Med Chem Lett (2013) 23, 2078-2082. PubMed  Europe PubMed DOI  I
  47. 2012
  48. Berry,C. and Goldberg,D.E.<br>Food vacuole plasmepsins<br>[ISSN:978-0-12-407744-7] (2012) 3, 98-103. DOI
  49. Bhaumik,P., Gustchina,A. and Wlodawer,A.<br>Structural studies of vacuolar plasmepsins<br>Biochim Biophys Acta (2012) 1824, 207-223. PubMed  Europe PubMed DOI  S
  50. Dali,B., Keita,M., Megnassan,E., Frecer,V. and Miertus,S.<br>Insight into selectivity of peptidomimetic inhibitors with modified statine core for plasmepsin II of Plasmodium falciparum over human cathepsin D<br>Chem Biol Drug Des (2012) 79, 411-430. PubMed  Europe PubMed DOI  I
  51. Meyers,M.J. and Goldberg,D.E.<br>Recent advances in plasmepsin medicinal chemistry and implications for future antimalarial drug discovery efforts<br>Curr Top Med Chem (2012) 12, 445-455. PubMed  Europe PubMed DOI  I
  52. Saify,Z.S., Azim,M.K., Ahmad,W., Nisa,M., Goldberg,D.E., Hussain,S.A., Akhtar,S., Akram,A., Arayne,A., Oksman,A. and Khan,I.A.<br>New benzimidazole derivatives as antiplasmodial agents and plasmepsin inhibitors: synthesis and analysis of structure-activity relationships<br>Bioorg Med Chem Lett (2012) 22, 1282-1286. PubMed  Europe PubMed DOI  I
  53. 2011
  54. Chullai,C., Nongrum,E. and Namdeo,R.<br>Proposing de-novo generated, iteratively optimized new lead molecules targeting Plasmodium falciparum plasmepsin-II frederick<br>Int J ChemTech Res (2011) 3, 1538-1547.  I
  55. Gil,L., Valiente,P.A., Pascutti,P.G. and Pons,T.<br>Computational perspectives into plasmepsins structure-function relationship: implications to inhibitors design<br>J Trop Med (2011) 2011, 657483-657483. PubMed  Europe PubMed DOI  PMC  EPMC  V
  56. McKay,P.B., Peters,M.B., Carta,G., Flood,C.T., Dempsey,E., Bell,A., Berry,C., Lloyd,D.G. and Fayne,D.<br>Identification of plasmepsin inhibitors as selective anti-malarial agents using ligand based drug design<br>Bioorg Med Chem Lett (2011) 21, 3335-3341. PubMed  Europe PubMed DOI  I
  57. Ojha,P.K. and Roy,K.<br>Exploring molecular docking and QSAR studies of plasmepsin-II inhibitor di-tertiary amines as potential antimalarial compounds<br>Mol Simul (2011) 37, 779-803. DOI  I
  58. Saify,Z.S., Nisa,M., Azhar,K.F., Azim,M.K., Rasheed,H., Mushtaq,N., Arain,M.A., Haider,S., Khanum,M. and Ahmed,W.<br>Characterisation of Plasmodium falciparum aspartic protease inhibition by piperidine derivatives<br>Nat Prod Res (2011) 25, 1965-1968. PubMed  Europe PubMed DOI  I
  59. Steiner,D., Oostenbrink,C., Diederich,F., Zurcher,M. and van Gunsteren,W.F.<br>Calculation of binding free energies of inhibitors to plasmepsin II<br>J Comput Chem (2011) 32, 1801-1812. PubMed  Europe PubMed DOI  I
  60. Xiao,H., Dee,D. and Yada,R.Y.<br>The native conformation of plasmepsin II is kinetically trapped at neutral pH<br>Arch Biochem Biophys (2011) 513, 102-109. PubMed  Europe PubMed DOI
  61. 2010
  62. Ahmed,W., Rani,M., Khan,I.A., Iqbal,A., Khan,K.M., Haleem,M.A. and Azim,M.K.<br>Characterisation of hydrazides and hydrazine derivatives as novel aspartic protease inhibitors<br>J Enzyme Inhib Med Chem (2010) 25, 673-678. PubMed  Europe PubMed DOI  I
  63. Friedman,R. and Caflisch,A.<br>On the orientation of the catalytic dyad in aspartic proteases<br>Proteins (2010) 78, 1575-1582. PubMed  Europe PubMed DOI  S
  64. Gupta,D., Yedidi,R.S., Varghese,S., Kovari,L.C. and Woster,P.M.<br>Mechanism-based inhibitors of the aspartyl protease plasmepsin II as potential antimalarial agents<br>J Med Chem (2010) 53, 4234-4247. PubMed  Europe PubMed DOI  I
  65. Luksch,T., Blum,A., Klee,N., Diederich,W.E., Sotriffer,C.A. and Klebe,G.<br>Pyrrolidine derivatives as plasmepsin inhibitors: binding mode analysis assisted by molecular dynamics simulations of a highly flexible protein<br>ChemMedChem (2010) 5, 443-454. PubMed  Europe PubMed DOI  I
  66. Miura,T., Hidaka,K., Uemura,T., Kashimoto,K., Hori,Y., Kawasaki,Y., Ruben,A.J., Freire,E., Kimura,T. and Kiso,Y.<br>Improvement of both plasmepsin inhibitory activity and antimalarial activity by 2-aminoethylamino substitution<br>Bioorg Med Chem Lett (2010) 20, 4836-4839. PubMed  Europe PubMed DOI  I
  67. Mohapatra,S.C., Tiwari,H.K., Singla,M., Rathi,B., Sharma,A., Mahiya,K., Kumar,M., Sinha,S. and Chauhan,S.S.<br>Antimalarial evaluation of copper(II) nanohybrid solids: inhibition of plasmepsin II, a hemoglobin-degrading malarial aspartic protease from Plasmodium falciparum<br>J Biol Inorg Chem (2010) 15, 373-385. PubMed  Europe PubMed DOI  I
  68. Parr-Vasquez,C.L. and Yada,R.Y.<br>Functional chimera of porcine pepsin prosegment and Plasmodium falciparum plasmepsin II<br>Protein Eng Des Sel (2010) 23, 19-26. PubMed  Europe PubMed DOI
  69. Valiente,P.A., Gil,A., Batista,P.R., Caffarena,E.R., Pons,T. and Pascutti,P.G.<br>New parameterization approaches of the LIE method to improve free energy calculations of PlmII-inhibitors complexes<br>J Comput Chem (2010) 31, 2723-2734. PubMed  Europe PubMed DOI  I
  70. 2009
  71. Degliesposti,G., Kasam,V., Da Costa,A., Kang,H.K., Kim,N., Kim,D.W., Breton,V., Kim,D. and Rastelli,G.<br>Design and discovery of plasmepsin II inhibitors using an automated workflow on large-scale grids<br>ChemMedChem (2009) 4, 1164-1173. PubMed  Europe PubMed DOI  I
  72. Dell'Agli,M., Galli,G.V., Corbett,Y., Taramelli,D., Lucantoni,L., Habluetzel,A., Maschi,O., Caruso,D., Giavarini,F., Romeo,S., Bhattacharya,D. and Bosisio,E.<br>Antiplasmodial activity of Punica granatum L. fruit rind<br>J Ethnopharmacol (2009) 125, 279-285. PubMed  Europe PubMed DOI  I
  73. Fah,C., Hardegger,L.A., Baitsch,L., Schweizer,W.B., Meyer,S., Bur,D. and Diederich,F.<br>New organofluorine building blocks: inhibition of the malarial aspartic proteases plasmepsin II and IV by alicyclic alpha,alpha-difluoroketone hydrates<br>Org Biomol Chem (2009) 7, 3947-3957. PubMed  Europe PubMed DOI  I
  74. Friedman,R. and Caflisch,A.<br>Discovery of plasmepsin inhibitors by fragment-based docking and consensus scoring<br>ChemMedChem (2009) 4, 1317-1326. PubMed  Europe PubMed DOI  I
  75. Moura,P.A., Dame,J.B. and Fidock,D.A.<br>Role of Plasmodium falciparum digestive vacuole plasmepsins in the specificity and antimalarial mode of action of cysteine and aspartic protease inhibitors<br>Antimicrobial Agents Chemother (2009) 53, 4968-4978. PubMed  Europe PubMed DOI  I
  76. Orrling,K.M., Marzahn,M.R., Gutierrez-de-Teran,H., Aqvist,J., Dunn,B.M. and Larhed,M.<br>alpha-Substituted norstatines as the transition-state mimic in inhibitors of multiple digestive vacuole malaria aspartic proteases<br>Bioorg Med Chem (2009) 17, 5933-5949. PubMed  Europe PubMed DOI  I
  77. Ramirez,A.R., Guerra,Y., Otero,A., Garcia,B., Berry,C., Mendiola,J., Hernandez-Zanui,A. and Chavez,M.<br>Generation of an affinity matrix useful in the purification of natural inhibitors of plasmepsin II, an antimalarial-drug target<br>Biotechnol Appl Biochem (2009) 52, 149-157. PubMed  Europe PubMed DOI  I
  78. Robbins,A.H., Dunn,B.M., Agbandje-McKenna,M. and McKenna,R.<br>Crystallographic evidence for noncoplanar catalytic aspartic acids in plasmepsin II resides in the Protein Data Bank<br>Acta Crystallogr D Biol Crystallogr (2009) 65, 294-296. PubMed  Europe PubMed DOI  S
  79. 2008
  80. Aberathne,P., Mahabaduge,J. and Silva,S.J.<br>Computer aided docking of small molecules to the active site of the malarial aspartic protease, plasmepsin II<br>J Natl Sci Found Sri Lanka (2008) 36, 171-178.  I
  81. Azim,M.K., Ahmed,W., Khan,I.A., Rao,N.A. and Khan,K.M.<br>Identification of acridinyl hydrazides as potent aspartic protease inhibitors<br>Bioorg Med Chem Lett (2008) 18, 3011-3015. PubMed  Europe PubMed DOI  I
  82. Drew,M.E., Banerjee,R., Uffman,E.W., Gilbertson,S., Rosenthal,P.J. and Goldberg,D.E.<br>Plasmodium food vacuole plasmepsins are activated by falcipains<br>J Biol Chem (2008) 283, 12870-12876. PubMed  Europe PubMed DOI  PMC  EPMC
  83. Friedman,R. and Caflisch,A.<br>Pepsinogen-like activation intermediate of plasmepsin II revealed by molecular dynamics analysis<br>Proteins (2008) 73, 814-827. PubMed  Europe PubMed DOI
  84. Hidaka,K., Kimura,T., Ruben,A.J., Uemura,T., Kamiya,M., Kiso,A., Okamoto,T., Tsuchiya,Y., Hayashi,Y., Freire,E. and Kiso,Y.<br>Antimalarial activity enhancement in hydroxymethylcarbonyl (HMC) isostere-based dipeptidomimetics targeting malarial aspartic protease plasmepsin<br>Bioorg Med Chem (2008) 16, 10049-10060. PubMed  Europe PubMed DOI  I
  85. Luksch,T., Chan,N.S., Brass,S., Sotriffer,C.A., Klebe,G. and Diederich,W.E.<br>Computer-aided design and synthesis of nonpeptidic plasmepsin II and IV inhibitors<br>ChemMedChem (2008) 3, 1323-1336. PubMed  Europe PubMed DOI  I
  86. Rumsh,L.D., Mikhailova,A.G., Mikhura,I.V., Prudchenko,I.A., Chikin,L.D., Mikhaleva,I.I., Kaliberda,E.N., Dergousova,N.I., Mel'nikov,E.E. and Formanovskii,A.A.<br>[Selective inhibitors of plasmepsin II from Plasmodium falciparum based on pepstatin]<br>Bioorg Khim (2008) 34, 739-746. PubMed  Europe PubMed  I
  87. Rumsh,L.D., Mikhailova,A.G., Mikhura,I.V., Prudchenko,I.A., Chikin,L.D., Mikhaleva,I.I., Kaliberda,E.N., Dergousova,N.I., Mel'nikov,E.E. and Formanovskii,A.A.<br>Selective inhibitors of plasmepsin II of Plasmodium falciparum on the basis of pepstatin<br>Russ J Bioorganic Chem (2008) 34, 660-667. DOI  I
  88. Zurcher,M., Gottschalk,T., Meyer,S., Bur,D. and Diederich,F.<br>Exploring the flap pocket of the antimalarial target plasmepsin II: the "55 % rule" applied to enzymes<br>ChemMedChem (2008) 3, 237-240. PubMed  Europe PubMed DOI
  89. 2007
  90. Bonilla,J.A., Moura,P.A., Bonilla,T.D., Yowell,C.A., Fidock,D.A. and Dame,J.B.<br>Effects on growth, hemoglobin metabolism and paralogous gene expression resulting from disruption of genes encoding the digestive vacuole plasmepsins of Plasmodium falciparum<br>Int J Parasitol (2007) 37, 317-327. PubMed  Europe PubMed DOI  K
  91. Bonilla,J.A., Bonilla,T.D., Yowell,C.A., Fujioka,H. and Dame,J.B.<br>Critical roles for the digestive vacuole plasmepsins of Plasmodium falciparum in vacuolar function<br>Mol Microbiol (2007) 65, 64-75. PubMed  Europe PubMed DOI  K
  92. Friedman,R. and Caflisch,A.<br>The protonation state of the catalytic aspartates in plasmepsin II<br>FEBS Lett (2007) 581, 4120-4124. PubMed  Europe PubMed DOI
  93. Hidaka,K., Kimura,T., Tsuchiya,Y., Kamiya,M., Ruben,A.J., Freire,E., Hayashi,Y. and Kiso,Y.<br>Additional interaction of allophenylnorstatine-containing tripeptidomimetics with malarial aspartic protease plasmepsin II<br>Bioorg Med Chem Lett (2007) 17, 3048-3052. PubMed  Europe PubMed DOI  I
  94. Kasam,V., Zimmermann,M., Maass,A., Schwichtenberg,H., Wolf,A., Jacq,N., Breton,V. and Hofmann-Apitius,M.<br>Design of new plasmepsin inhibitors: a virtual high throughput screening approach on the EGEE grid<br>J Chem Inf Model (2007) 47, 1818-1828. PubMed  Europe PubMed DOI  I
  95. 2006
  96. Andrews,K.T., Fairlie,D.P., Madala,P.K., Ray,J., Wyatt,D.M., Hilton,P.M., Melville,L.A., Beattie,L., Gardiner,D.L., Reid,R.C., Stoermer,M.J., Skinner-Adams,T., Berry,C. and McCarthy,J.S.<br>Potencies of human immunodeficiency virus protease inhibitors in vitro against Plasmodium falciparum and in vivo against murine malaria<br>Antimicrob Agents Chemother (2006) 50, 639-648. PubMed  Europe PubMed DOI  PMC  EPMC  I
  97. [YEAR:27-6-2006]Bjelic,S. and Aqvist,J.<br>Catalysis and linear free energy relationships in aspartic proteases<br>Biochemistry (27-6-2006) 45, 7709-7723. PubMed  Europe PubMed DOI
  98. Boss,C., Corminboeuf,O., Grisostomi,C., Meyer,S., Jones,A.F., Prade,L., Binkert,C., Fischli,W., Weller,T. and Bur,D.<br>Achiral, cheap, and potent inhibitors of plasmepsins I, II, and IV<br>ChemMedChem (2006) 1, 1341-1345. PubMed  Europe PubMed DOI  S  I
  99. [YEAR:14-12-2006]Dell'Agli,M., Parapini,S., Galli,G., Vaiana,N., Taramelli,D., Sparatore,A., Liu,P., Dunn,B.M., Bosisio,E. and Romeo,S.<br>High antiplasmodial activity of novel plasmepsins I and II inhibitors<br>J Med Chem (14-12-2006) 49, 7440-7449. PubMed  Europe PubMed DOI  I
  100. [YEAR:21-11-2006]Ersmark,K., Nervall,M., Gutierrez-de-Teran,H., Hamelink,E., Janka,L.K., Clemente,J.C., Dunn,B.M., Gogoll,A., Samuelsson,B., Qvist,J. and Hallberg,A.<br>Macrocyclic inhibitors of the malarial aspartic proteases plasmepsin I, II, and IV<br>Bioorg Med Chem (21-11-2006) 14, 2197-2208. PubMed  Europe PubMed DOI  I
  101. Hof,F., Schutz,A., Fah,C., Meyer,S., Bur,D., Liu,J., Goldberg,D.E. and Diederich,F.<br>Starving the malaria parasite: inhibitors active against the aspartic proteases plasmepsins I, II, and IV<br>Angew Chem Int Ed Engl (2006) 45, 2138-2141. PubMed  Europe PubMed DOI  I
  102. Kim,Y.M., Lee,M.H., Piao,T.G., Lee,J.W., Kim,J.H., Lee,S., Choi,K.M., Jiang,J.H., Kim,T.U. and Park,H.<br>Prodomain processing of recombinant plasmepsin II and IV, the aspartic proteases of Plasmodium falciparum, is auto- and trans-catalytic<br>J Biochem (2006) 139, 189-195. PubMed  Europe PubMed DOI
  103. Liu,J., Istvan,E.S. and Goldberg,D.E.<br>Hemoglobin-degrading plasmepsin II is active as a monomer<br>J Biol Chem (2006) 281, 38682-38688. PubMed  Europe PubMed DOI
  104. Sriwilaijaroen,N., Liu,M., Go,M.L. and Wilairat,P.<br>Plasmepsin II inhibitory activity of alkoxylated and hydroxylated chalcones<br>Southeast Asian J Trop Med Public Health (2006) 37, 607-612. PubMed  Europe PubMed  I
  105. Weik,S., Luksch,T., Evers,A., Bottcher,J., Sotriffer,C.A., Hasilik,A., Loffler,H.G., Klebe,G. and Rademann,J.<br>The potential of P1 site alterations in peptidomimetic protease inhibitors as suggested by virtual screening and explored by the use of C-C-coupling reagents<br>ChemMedChem (2006) 1, 445-457. PubMed  Europe PubMed DOI  I
  106. 2005
  107. [YEAR:15-2-2005]Beyer,B.B., Johnson,J.V., Chung,A.Y., Li,T., Madabushi,A., Agbandje-McKenna,M., McKenna,R., Dame,J.B. and Dunn,B.M.<br>Active-site specificity of digestive aspartic peptidases from the four species of Plasmodium that infect humans using chromogenic combinatorial peptide libraries<br>Biochemistry (15-2-2005) 44, 1768-1779. PubMed  Europe PubMed DOI  I
  108. [YEAR:22-9-2005]Ersmark,K., Nervall,M., Hamelink,E., Janka,L.K., Clemente,J.C., Dunn,B.M., Blackman,M.J., Samuelsson,B., Aqvist,J. and Hallberg,A.<br>Synthesis of malarial plasmepsin inhibitors and prediction of binding modes by molecular dynamics simulations<br>J Med Chem (22-9-2005) 48, 6090-6106. PubMed  Europe PubMed DOI  I
  109. [YEAR:1-12-2005]Istvan,E.S. and Goldberg,D.E.<br>Distal substrate interactions enhance plasmepsin activity<br>J Biol Chem (1-12-2005) 280, 6890-6896. PubMed  Europe PubMed DOI
  110. [YEAR:30-6-2005]Johansson,P.O., Lindberg,J., Blackman,M.J., Kvarnstrom,I., Vrang,L., Hamelink,E., Hallberg,A., Rosenquist,A. and Samuelsson,B.<br>Design and synthesis of potent inhibitors of plasmepsin I and II: X-ray crystal structure of inhibitor in complex with plasmepsin II<br>J Med Chem (30-6-2005) 48, 4400-4409. PubMed  Europe PubMed DOI  S  I
  111. [YEAR:28-10-2005]Liu,J., Gluzman,I.Y., Drew,M.E. and Goldberg,D.E.<br>The role of Plasmodium falciparum food vacuole plasmepsins<br>J Biol Chem (28-10-2005) 280, 1432-1437. PubMed  Europe PubMed DOI
  112. [YEAR:19-4-2005]Prade,L., Jones,A.F., Boss,C., Richard-Bildstein,S., Meyer,S., Binkert,C. and Bur,D.<br>X-ray structure of plasmepsin II complexed with a potent achiral inhibitor<br>J Biol Chem (19-4-2005) 280, 23837-23843. PubMed  Europe PubMed DOI  S  I
  113. 2004
  114. Abdel-Rahman,H.M., Kimura,T., Hidaka,K., Kiso,A., Nezami,A., Freire,E., Hayashi,Y. and Kiso,Y.<br>Design of inhibitors against HIV, HTLV-I, and Plasmodium falciparum aspartic proteases<br>Biol Chem (2004) 385, 1035-1039. PubMed  Europe PubMed DOI
  115. Alexov,E.<br>Calculating proton uptake/release and binding free energy taking into account ionization and conformation changes induced by protein-inhibitor association: application to plasmepsin, cathepsin D and endothiapepsin-pepstatin complexes<br>Proteins (2004) 56, 572-584. PubMed  Europe PubMed DOI  I
  116. Berry,C. and Goldberg,D.E.<br>Plasmepsins<br>[ISSN:0-12-079610-4] (2004) 2, 70-73.  V
  117. Berry,C. and Goldberg,D.E.<br>Plasmepsin II<br>[ISSN:0-12-079610-4] (2004) 2, 73-75.  V
  118. Beyer,B.B., Goldfarb,N.E. and Dunn,B.M.<br>Expression, purification, and characterization of aspartic endopeptidases: Plasmodium plasmepsins and "short" recombinant human pseudocathepsin<br>Curr Protoc Protein Sci (2004) Unit 21.14, Unit 21.14- PubMed  Europe PubMed DOI  E
  119. [YEAR:1-1-2004]Ersmark,K., Feierberg,I., Bjelic,S., Hamelink,E., Hackett,F., Blackman,M.J., Hulten,J., Samuelsson,B., Aqvist,J. and Hallberg,A.<br>Potent inhibitors of the Plasmodium falciparum enzymes plasmepsin I and II devoid of cathepsin D inhibitory activity<br>J Med Chem (1-1-2004) 47, 110-122. PubMed  Europe PubMed DOI  I
  120. [YEAR:17-6-2004]Johansson,P.O., Chen,Y., Belfrage,A.K., Blackman,M.J., Kvarnstrom,I., Jansson,K., Vrang,L., Hamelink,E., Hallberg,A., Rosenquist,A. and Samuelsson,B.<br>Design and synthesis of potent inhibitors of the malaria aspartyl proteases plasmepsin I and II. Use of solid-phase synthesis to explore novel statine motifs<br>J Med Chem (17-6-2004) 47, 3353-3366. PubMed  Europe PubMed DOI  I
  121. [YEAR:5-1-2004]Klemba,M., Beatty,W., Gluzman,I. and Goldberg,D.E.<br>Trafficking of plasmepsin II to the food vacuole of the malaria parasite Plasmodium falciparum<br>J Cell Biol (5-1-2004) 164, 47-56. PubMed  Europe PubMed DOI  PMC  EPMC
  122. [YEAR:24-12-2004]Omara-Opyene,A.L., Moura,P.A., Sulsona,C.R., Bonilla,J.A., Yowell,C.A., Fujioka,H., Fidock,D.A. and Dame,J.B.<br>Genetic disruption of the Plasmodium falciparum digestive vacuole plasmepsins demonstrates their functional redundancy<br>J Biol Chem (24-12-2004) 279, 54088-54096. PubMed  Europe PubMed DOI
  123. [YEAR:7-6-2004]Romeo,S., Dell'Agli,M., Parapini,S., Rizzi,L., Galli,G., Mondani,M., Sparatore,A., Taramelli,D. and Bosisio,E.<br>Plasmepsin II inhibition and antiplasmodial activity of Primaquine-Statine 'double-drugs'<br>Bioorg Med Chem Lett (7-6-2004) 14, 2931-2934. PubMed  Europe PubMed DOI
  124. [YEAR:1-3-2004]Salas,E., Ramirez,A., Otero-Bilbao,A., Vazquez,R., Reyes,O., Mendiola,J., Duarte,C.A., Otero-Gonzalez,A., Gutierrez,O.A. and Chavez,M.A.<br>A heterogeneous enzymatic assay for quantification of plasmepsin II activity and the evaluation of its inhibitors<br>J Pharm Biomed Anal (1-3-2004) 34, 833-840. PubMed  Europe PubMed DOI  A
  125. 2003
  126. [YEAR:14-3-2003]Asojo,O.A., Gulnik,S.V., Afonina,E., Yu,B., Ellman,J.A., Haque,T.S. and Silva,A.M.<br>Novel uncomplexed and complexed structures of plasmepsin II, an aspartic protease from Plasmodium falciparum<br>J Mol Biol (14-3-2003) 327, 173-181. PubMed  Europe PubMed DOI  S  I
  127. Banerjee,R., Francis,S.E. and Goldberg,D.E.<br>Food vacuole plasmepsins are processed at a conserved site by an acidic convertase activity in Plasmodium falciparum<br>Mol Biochem Parasitol (2003) 129, 157-165. PubMed  Europe PubMed DOI
  128. Boss,C., Richard-Bildstein,S., Weller,T., Fischli,W., Meyer,S. and Binkert,C.<br>Inhibitors of the Plasmodium falciparum parasite aspartic protease plasmepsin II as potential antimalarial agents<br>Curr Med Chem (2003) 10, 883-907. PubMed  Europe PubMed DOI  I
  129. Carcache,D.A., Hortner,S.R., Seiler,P., Diederich,F., Dorn,A., Marki,H.P., Binkert,C. and Bur,D.<br>Development of a new class of inhibitors for the malarial aspartic protease plasmepsin II based on a central 7-azabicyclo[2.2.1]heptane scaffold<br>Helv Chim Acta (2003) 86, 2173-2191. DOI  I
  130. Carcache,D.A., Hortner,S.R., Bertogg,A., Diederich,F., Dorn,A., Marki,H.P., Binkert,C. and Bur,D.<br>A new class of inhibitors for the malarial aspartic protease plasmepsin II based on a central 11-azatricyclo[6.2.1.02,7]undeca-2,4,6-triene scaffold<br>Helv Chim Acta (2003) 86, 2192-2209.  I
  131. [YEAR:5-8-2003]Dahlgren,A., Kvarnstrom,I., Vrang,L., Hamelink,E., Hallberg,A., Rosenquist,A. and Samuelsson,B.<br>New inhibitors of the malaria aspartyl proteases plasmepsin I and II<br>Bioorg Med Chem (5-8-2003) 11, 3423-3437. PubMed  Europe PubMed DOI
  132. Dahlgren,A., Kvarnstrom,I., Vrang,L., Hamelink,E., Hallberg,A., Rosenquist,A. and Samuelsson,B.<br>Solid-phase library synthesis of reversed-statine type inhibitors of the malarial aspartyl proteases plasmepsin I and II<br>Bioorg Med Chem (2003) 11, 827-841. PubMed  Europe PubMed DOI  I
  133. [YEAR:15-8-2003]Ersmark,K., Feierberg,I., Bjelic,S., Hulten,J., Samuelsson,B., Aqvist,J. and Hallberg,A.<br>C2-symmetric inhibitors of Plasmodium falciparum plasmepsin II: synthesis and theoretical predictions<br>Bioorg Med Chem (15-8-2003) 11, 3723-3733. PubMed  Europe PubMed DOI
  134. [YEAR:22-7-2003]Nezami,A., Kimura,T., Hidaka,K., Kiso,A., Liu,J., Kiso,Y., Goldberg,D.E. and Freire,E.<br>High-affinity inhibition of a family of Plasmodium falciparum proteases by a designed adaptive inhibitor<br>Biochemistry (22-7-2003) 42, 8459-8464. PubMed  Europe PubMed DOI  I
  135. [YEAR:27-2-2003]Noteberg,D., Hamelink,E., Hulten,J., Wahlgren,M., Vrang,L., Samuelsson,B. and Hallberg,A.<br>Design and synthesis of plasmepsin I and plasmepsin II inhibitors with activity in Plasmodium falciparum-infected cultured human erythrocytes<br>J Med Chem (27-2-2003) 46, 734-746. PubMed  Europe PubMed DOI
  136. Noteberg,D., Schaal,W., Hamelink,E., Vrang,L. and Larhed,M.<br>High-speed optimization of inhibitors of the malarial proteases plasmepsin I and II<br>J Comb Chem (2003) 5, 456-464. PubMed  Europe PubMed DOI  I
  137. [YEAR:3-4-2003]Oscarsson,K., Oscarson,S., Vrang,L., Hamelink,E., Hallberg,A. and Samuelsson,B.<br>New potent C2-symmetric malaria plasmepsin I and II inhibitors<br>Bioorg Med Chem (3-4-2003) 11, 1235-1246. PubMed  Europe PubMed DOI
  138. 2002
  139. Asojo,O.A., Afonina,E., Gulnik,S.V., Yu,B., Erickson,J.W., Randad,R., Medjahed,D. and Silva,A.M.<br>Structures of Ser205 mutant plasmepsin II from Plasmodium falciparum at 1.8 A in complex with the inhibitors rs367 and rs370<br>Acta Crystallogr D Biol Crystallogr (2002) 58, 2001-2008. PubMed  Europe PubMed DOI  S  I
  140. [YEAR:22-1-2002]Banerjee,R., Liu,J., Beatty,W., Pelosof,L., Klemba,M. and Goldberg,D.E.<br>Four plasmepsins are active in the Plasmodium falciparum food vacuole, including a protease with an active-site histidine<br>Proc Natl Acad Sci U S A (22-1-2002) 99, 990-995. PubMed  Europe PubMed DOI  PMC  EPMC
  141. [YEAR:4-11-2002]Carcache,D.A., Hortner,S.R., Bertogg,A., Binkert,C., Bur,D., Marki,H.P., Dorn,A. and Diederich,F.<br>De novo design, synthesis, and in vitro evaluation of a new class of nonpeptidic inhibitors of the malarial enzyme plasmepsin II<br>Chembiochem (4-11-2002) 3, 1137-1141. PubMed  Europe PubMed DOI  I
  142. Flotow,H., Leong,C.Y. and Buss,A.D.<br>Development of a plasmepsin II fluorescence polarization assay suitable for high throughput antimalarial drug discovery<br>J Biomol Screen (2002) 7, 367-371. PubMed  Europe PubMed DOI  A
  143. Nezami,A., Luque,I., Kimura,T., Kiso,Y. and Freire,E.<br>Identification and characterization of allophenylnorstatine-based inhibitors of plasmepsin II, an antimalarial target<br>Biochemistry (2002) 41, 2273-2280. PubMed  Europe PubMed DOI  I
  144. Nezami,A. and Freire,E.<br>The integration of genomic and structural information in the development of high affinity plasmepsin inhibitors<br>Int J Parasitol (2002) 32, 1669-1676. PubMed  Europe PubMed DOI  I
  145. [YEAR:25-10-2002]Siripurkpong,P., Yuvaniyama,J., Wilairat,P. and Goldberg,D.E.<br>Active site contribution to specificity of the aspartic proteases plasmepsins I and II<br>J Biol Chem (25-10-2002) 277, 41009-41013. PubMed  Europe PubMed DOI
  146. 2001
  147. [YEAR:19-10-2001]Brinkworth,R.I., Prociv,P., Loukas,A. and Brindley,P.J.<br>Hemoglobin-degrading, aspartic proteases of blood-feeding parasites: substrate specificity revealed by homology models<br>J Biol Chem (19-10-2001) 276, 38844-38851. PubMed  Europe PubMed DOI  I
  148. Coombs,G.H., Goldberg,D.E., Klemba,M., Berry,C., Kay,J. and Mottram,J.C.<br>Aspartic proteases of Plasmodium falciparum and other parasitic protozoa as drug targets<br>Trends Parasitol (2001) 17, 532-537. PubMed  Europe PubMed DOI
  149. Jiang,S.P., Prigge,S.T., Wei,L., Gao,Y.E., Hudson,T.H., Gerena,L., Dame,J.B. and Kyle,D.E.<br>New class of small nonpeptidyl compounds blocks Plasmodium falciparum development in vitro by inhibiting plasmepsins<br>Antimicrobial Agents Chemother (2001) 45, 2577-2584. PubMed  Europe PubMed DOI  PMC  EPMC
  150. Pranav Kumar,S.K. and Kulkarni,V.M.<br>Molecular dynamics simulations of the three dimensional model of plasmepsin II-peptidic inhibitor complexes<br>Drug Des Discov (2001) 17, 293-313. PubMed  Europe PubMed  I
  151. 1999
  152. Bernstein,N.K., Cherney,M.M., Loetscher,H., Ridley,R.G. and James,M.N.<br>Crystal structure of the novel aspartic proteinase zymogen proplasmepsin II from Plasmodium falciparum<br>Nat Struct Biol (1999) 6, 32-37. PubMed  Europe PubMed DOI  S
  153. Bernstein,N.K. and James,M.N.<br>Novel ways to prevent proteolysis - prophytepsin and proplasmepsin II<br>Curr Opin Struct Biol (1999) 9, 684-689. PubMed  Europe PubMed  S
  154. [YEAR:22-4-1999]Haque,T.S., Skillman,A.G., Lee,C.E., Habashita,H., Gluzman,I.Y., Ewing,T.J., Goldberg,D.E., Kuntz,I.D. and Ellman,J.A.<br>Potent, low-molecular-weight non-peptide inhibitors of malarial aspartyl protease plasmepsin II<br>J Med Chem (22-4-1999) 42, 1428-1440. PubMed  Europe PubMed DOI  I
  155. [YEAR:14-5-1999]Le Bonniec,S., Deregnaucourt,C., Redeker,V., Banerjee,R., Grellier,P., Goldberg,D.E. and Schrevel,J.<br>Plasmepsin II, an acidic hemoglobinase from the Plasmodium falciparum food vacuole, is active at neutral pH on the host erythrocyte membrane skeleton<br>J Biol Chem (14-5-1999) 274, 14218-14223. PubMed  Europe PubMed DOI
  156. [YEAR:9-7-1999]Tyas,L., Gluzman,I., Moon,R.P., Rupp,K., Westling,J., Ridley,R.G., Kay,J., Goldberg,D.E. and Berry,C.<br>Naturally-occurring and recombinant forms of the aspartic proteinases plasmepsins I and II from the human malaria parasite Plasmodium falciparum<br>FEBS Lett (9-7-1999) 454, 210-214. PubMed  Europe PubMed DOI
  157. Westling,J., Cipullo,P., Hung,S.H., Saft,H., Dame,J.B. and Dunn,B.M.<br>Active site specificity of plasmepsin II<br>Protein Sci (1999) 8, 2001-2009. PubMed  Europe PubMed DOI  PMC  EPMC
  158. 1998
  159. [YEAR:17-11-1998]Carroll,C.D., Johnson,T.O., Tao,S., Lauri,G., Orlowski,M., Gluzman,I.Y., Goldberg,D.E. and Dolle,R.E.<br>Evaluation of a structure-based statine cyclic diamino amide encoded combinatorial library against plasmepsin II and cathepsin D<br>Bioorg Med Chem Lett (17-11-1998) 8, 3203-3206. PubMed  Europe PubMed  I
  160. [YEAR:8-9-1998]Carroll,C.D., Patel,H., Johnson,T.O., Guo,T., Orlowski,M., He,Z.M., Cavallaro,C.L., Guo,J., Oksman,A., Gluzman,I.Y., Connelly,J., Chelsky,D., Goldberg,D.E. and Dolle,R.E.<br>Identification of potent inhibitors of Plasmodium falciparum plasmepsin II from an encoded statine combinatorial library<br>Bioorg Med Chem Lett (8-9-1998) 8, 2315-2320. PubMed  Europe PubMed DOI  I
  161. Silva,A.M., Lee,A.Y., Erickson,J.W. and Goldberg,D.E.<br>Structural analysis of plasmepsin II. A comparison with human aspartic proteases<br>Adv Exp Med Biol (1998) 436, 363-373. PubMed  Europe PubMed
  162. Tyas,L., Moon,R.P., Loetscher,H., Dunn,B.M., Kay,J., Ridley,R.G. and Berry,C.<br>Plasmepsins I and II from the malarial parasite Plasmodium falciparum<br>Adv Exp Med Biol (1998) 436, 407-411. PubMed  Europe PubMed
  163. 1997
  164. Francis,S.E., Sullivan,D.J., Jr. and Goldberg,D.E.<br>Hemoglobin metabolism in the malaria parasite Plasmodium falciparum<br>Annu Rev Microbiol (1997) 51, 97-123. PubMed  Europe PubMed DOI
  165. Francis,S.E., Banerjee,R. and Goldberg,D.E.<br>Biosynthesis and maturation of the malaria aspartic hemoglobinases plasmepsins I and II<br>J Biol Chem (1997) 272, 14961-14968. PubMed  Europe PubMed DOI
  166. Westling,J., Yowell,C.A., Majer,P., Erickson,J.W., Dame,J.B. and Dunn,B.M.<br>Plasmodium falciparum, P. vivax, and P. malariae: a comparison of the active site properties of plasmepsins cloned and expressed from three different species of the malaria parasite<br>Exp Parasitol (1997) 87, 185-193. PubMed  Europe PubMed DOI
  167. Xie,D., Gulnik,S., Collins,L., Gustchina,E., Suvorov,L. and Erickson,J.W.<br>Dissection of the pH dependence of inhibitor binding energetics for an aspartic protease: direct measurement of the protonation states of the catalytic aspartic acid residues<br>Biochemistry (1997) 36, 16166-16172. PubMed  Europe PubMed DOI  I
  168. 1996
  169. Luker,K.E., Francis,S.E., Gluzman,I.Y. and Goldberg,D.E.<br>Kinetic analysis of plasmepsins I and II, aspartic proteases of the Plasmodium falciparum digestive vacuole<br>Mol Biochem Parasitol (1996) 79, 71-78. PubMed  Europe PubMed DOI
  170. Silva,A.M., Lee,A.Y., Gulnik,S.V., Maier,P., Collins,J., Bhat,T.N., Collins,P.J., Cachau,R.E., Luker,K.E., Gluzman,I.Y., Francis,S.E., Oksman,A., Goldberg,D.E. and Erickson,J.W.<br>Structure and inhibition of plasmepsin II, a hemoglobin- degrading enzyme from Plasmodium falciparum<br>Proc Natl Acad Sci U S A (1996) 93, 10034-10039. PubMed  Europe PubMed DOI  PMC  EPMC  S
  171. 1994
  172. Dame,J.B., Reddy,G.R., Yowell,C.A., Dunn,B.M., Kay,J. and Berry,C.<br>Sequence, expression and modeled structure of an aspartic proteinase from the human malaria parasite Plasmodium falciparum<br>Mol Biochem Parasitol (1994) 64, 177-190. PubMed  Europe PubMed DOI
  173. Gluzman,I.Y., Francis,S.E., Oksman,A., Smith,C.E., Duffin,K.L. and Goldberg,D.E.<br>Order and specificity of the Plasmodium falciparum hemoglobin degradation pathway<br>J Clin Invest (1994) 93, 1602-1608. PubMed  Europe PubMed DOI  PMC  EPMC
  174. Hill,J., Tyas,L., Phylip,L.H., Kay,J., Dunn,B.M. and Berry,C.<br>High level expression and characterisation of plasmepsin II, an aspartic proteinase from Plasmodium falciparum<br>FEBS Lett (1994) 352, 155-158. PubMed  Europe PubMed DOI